West Pharmaceutical Services WST Total debt

Total debt at other companies

AptarGroupATR

$1.43B+32.7%

Halozyme TherapeuticsHALO

$2.18B+41.7%

AVT

AvantorAVTR

$3.7B-12.8%

DowDOW

$18.67B+5.5%

DuPont de Nemours, Inc.DD

$3.17B-58.2%

Becton, Dickinson and CompanyBDX

——

FAQ

What is West Pharmaceutical Services's total debt?

West Pharmaceutical Services (WST) reported total debt of $316.5M in Q2 2026.

How has West Pharmaceutical Services's total debt changed year-over-year?

West Pharmaceutical Services's total debt increased by 2.7% year-over-year, from $308.2M to $316.5M.

What is the long-term trend for West Pharmaceutical Services's total debt?

Over 5 years (2020 to 2025), West Pharmaceutical Services's total debt has grown at a 0.0% compound annual growth rate (CAGR), from $325.7M to $326.2M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.